|
- Brand：Knowlux
- Model：Bottle/Aluminum foil bag/Drum/Customized to your needs
- Purity：99%
- Cas：157115-85-0
- Createtime： 2026-11-11
- Updatetime： 2026-11-03
| useage | cosmetic ingredient、research reagent、biochemical intermediate |
| deliveryInfo | |
| sample availble | yes |
| appearance | White Powder |
| aliasen | |
| supplyCapacity | 10MT/Month |
| harbor | Hong Kong, Shanghai, Shenzhen |
| minorder | 1KG |
| Molecular Formula: | C17H22N2O4 |
Noopept (GVS-111) | CAS 157115-85-0 | AMPA Receptor Modulator (Research Use Only) | Knowlux
Product Description
Noopept, CAS 157115-85-0, is a synthetic peptide-derived compound supplied by Knowlux for laboratory research use. It is also known as GVS-111, SGS-111, or Omberacetam, and its chemical name is N-(1-(phenylacetyl)-L-prolyl)glycine ethyl ester. The molecular formula is C17H22N2O4 and the molecular weight is 318.37 g/mol. Each lot is released with a lot-specific COA, MSDS and full analytical traceability.
Regulatory and safety clarification: Noopept is not approved by the FDA for any therapeutic indication, and is not a permitted dietary-supplement ingredient in the United States. It was developed in Russia in the 1990s and has been promoted and prescribed in Russia and neighbouring countries as a nootropic, but it lacks FDA or EMA marketing authorisation. GuideChem's 2026 export compliance white paper explicitly states that Noopept is an unapproved research compound and must not be marketed for memory, cognition, neuroprotection, treatment, or self-administration. Commercial listings describe it as a cognitive enhancer or nootropic powder; those designations attach to unregulated supplement markets and do not apply to, and are not represented by, this research-grade lot.
Product Parameters
| Item | Specification |
|---|---|
| Product Name | Noopept |
| Synonyms | GVS-111; SGS-111; Omberacetam; N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester; Ethyl 1-(phenylacetyl)-L-prolylglycinate |
| CAS No. | 157115-85-0 |
| Molecular Formula | C17H22N2O4 |
| Molecular Weight | 318.37 g/mol |
| Chemical Name | Ethyl 2-{[(2S)-1-(2-phenylacetyl)pyrrolidin-2-yl]formamido}acetate |
| Appearance | White to off-white crystalline powder |
| Melting Point | 94.0-98.0 C |
| Boiling Point | 547.3 +/- 50.0 C at 760 mmHg (predicted) |
| Density | 1.2 +/- 0.1 g/cm3 |
| Solubility | DMSO: >=100 mg/mL (314.10 mM) |
| Purity | >=98.0% (HPLC); >=99.0% available on request |
| Identity | Confirmed by LC-MS and 1H-NMR |
| Grade | Research grade |
| Counter-ion | Not applicable (neutral compound) |
| Moisture | <=1.0% (Karl Fischer) |
| Storage | -20 C (long-term) or 2-8 C (short-term), protected from light and moisture; desiccated |
| HS Code | 2933.79.00 |
| Packaging | 1 g / 5 g / 10 g / 50 g / 100 g / 1 kg foil bag or vial; bulk on request |
| MOQ | 10 g (research grade); 100 g (bulk) |
| Supply Ability | Gram to kilogram scale |
| Application | Laboratory research use only |
| Origin | China |
Product Details
1. Overview
Noopept is a synthetic dipeptide-like compound derived from the phenylacetyl derivative of L-proline and glycine ethyl ester. Structurally, it is a substituted prolyl-glycine ester rather than a classical racetam, though it is often discussed alongside racetams due to its nootropic research context. It was developed in Russia in the 1990s, with the original research interest focused on alcohol-induced brain damage and cognitive deficits. Knowlux supplies Noopept as a research-grade material for laboratory and analytical use; this supply is not intended for human administration and does not constitute a finished drug or supplement product.
2. Mechanism of Action (Research Context)
Published preclinical research describes Noopept as a compound that modulates AMPA receptor activity and exhibits neuroprotective effects in animal models. GuideChem's compliance white paper notes that release testing should confirm molecular structure, L-proline stereochemistry, assay, related substances, ester hydrolysis products, water content, residual solvents, and elemental impurities, using stability-indicating methods. It has been reported to influence neurotrophic factor levels (NGF and BDNF) and glutamatergic signalling in preclinical studies, though these findings are derived from animal models and have not been confirmed in human clinical trials. These descriptions are provided for scientific reference only. Knowlux makes no claims regarding the efficacy, safety, or suitability of this product for any human application. Promotion of Noopept for memory enhancement, cognitive improvement, neuroprotection, or any health benefit is not supported by Knowlux and is inconsistent with research-use-only supply.
3. Quality Control
| Test Item | Method |
|---|---|
| Purity | HPLC |
| Identity & molecular mass | LC-MS (deconvoluted) |
| Structural confirmation | 1H-NMR |
| L-Proline stereochemistry | Chiral HPLC or NMR (reported per lot) |
| Ester hydrolysis products | HPLC (reported per lot) |
| Moisture | Karl Fischer |
| Appearance | Visual |
| Residual solvents | GC (on request) |
| Heavy metals | ICP-MS (on request) |
4. Applications
-
Reference standard for Noopept analytical method development
-
In vitro AMPA receptor binding and functional assay development
-
Glutamatergic neurotransmission research models
-
Comparative studies of prolyl-glycine ester compounds
-
LC-MS and biochemical assay calibrators
5. Packaging, Storage & Shipping
Powder: amber glass vial or high-barrier foil bag under nitrogen headspace, sealed with tamper-evident closure. Secondary packing: light-protected carton with desiccant. Noopept is moisture-sensitive and should be protected from humidity during transit; cold-chain shipping with temperature logger where required. COA, MSDS, packing list and certificate of origin issued with each shipment.
6. Documentation Support
Per lot: COA, MSDS, certificate of origin, residual solvent statement, heavy metal statement, stereochemistry confirmation report. Specification summaries and audit support available on a project basis.
About Knowlux
Knowlux Biotechnology is a GMP-oriented manufacturer and supplier of peptides, APIs and fine-chemical research compounds, operating from Hubei, China. We serve research groups, CDMOs and distributors in more than 40 countries, and support contract synthesis, custom packaging and technical documentation requests.
Compliance Statement
This product is supplied for laboratory research use only. It is not for human or animal administration, not for diagnostic or therapeutic use, not for retail sale, and not for personal use. Noopept is not FDA-approved for any indication and is not a permitted dietary-supplement ingredient. It is an unapproved research compound and must not be marketed for memory, cognition, neuroprotection, treatment, or self-administration. WADA S0 addresses certain non-approved pharmacological substances; sport-related supply requires current-list review and end-use screening. Research context statements are for scientific reference only and do not constitute medical advice, promotional claims, or dosing guidance.
